Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report
Mov Disord Clin Pract
.
2015 May 22;2(2):127-134.
doi: 10.1002/mdc3.12130.
eCollection 2015 Jun.
Authors
Deborah A Hall
1
,
Maria João Forjaz
2
,
Lawrence I Golbe
3
,
Irene Litvan
4
,
Christine Ann M Payan
5
,
Christopher G Goetz
1
,
Albert F G Leentjens
6
,
Pablo Martinez-Martin
7
,
Anne Pavy-Le Traon
8
,
Cristina Sampaio
9
,
Bart Post
10
,
Glenn Stebbins
1
,
Daniel Weintraub
11
,
Anette Schrag
12
Affiliations
1
Department of Neurological Sciences Rush University Chicago Illinois USA.
2
National School of Public Health Health Institute Carlos III and REDISSEC Madrid Spain.
3
Department of Neurology Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey USA.
4
Department of Neurosciences University of California San Diego San Diego California USA.
5
Department de Pharmacologie Clinique Hôpital Pitié-Salpêtrière Assistance-Publique Hôpitaux de Paris (APHP) Paris France.
6
Department of Psychiatry Maastricht University Hospital Maastricht The Netherlands.
7
National Center of Epidemiology, and CIBERNED Carlos III Institute of Health Madrid Spain.
8
Reference Center for MSA University Hospital and INSERM U1048 Eq8 Toulouse France.
9
Laboratory of Clinical Pharmacology and Therapeutics Lisbon School of Medicine Lisbon Portugal.
10
Department of Neurology Radboudumc, Radboud University Medical Center Nijmegen The Netherlands.
11
Department of Psychiatry University of Pennsylvania School of Medicine Philadelphia Pennsylvania USA.
12
Department of Clinical Neuroscience Institute of Neurology University College London London United Kingdom.
PMID:
30363842
PMCID:
PMC6183172
DOI:
10.1002/mdc3.12130
No abstract available
Keywords:
progressive supranuclear palsy; rating scale.
Publication types
Review